Peptides: Hype Outpacing Proof
19:12–20:24 · 73s
Kara warns peptide enthusiasm rests on tiny studies and supply risks, contrasts it with GLP-1 drugs being rigorously studied, and flags public figures promoting unproven fixes.
19:12–20:24 · 73s
Kara warns peptide enthusiasm rests on tiny studies and supply risks, contrasts it with GLP-1 drugs being rigorously studied, and flags public figures promoting unproven fixes.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.